Načítá se...
Progress in Immunotherapy for Non-small Cell Lung Cancer
In recent years, the five-year survival rate of patients with advanced stage non-small cell lung cancer (NSCLC) remains low despite recent advances in surgery, irradiation, chemotherapy, and targeted therapy. Immunotherapy which utilizes the immune system to control and eradicate cancer is a viable...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Chinês |
| Vydáno: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2014-01-01
|
| Edice: | Chinese Journal of Lung Cancer |
| Témata: | |
| On-line přístup: | http://dx.doi.org/10.3779/j.issn.1009-3419.2014.01.06 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|